Amid concerns over effectiveness, govt ramping up Remdesivir production

Remdesivir may soon be dropped from ICMR's Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment.


A man holds boxes of Remdesivir, an antiviral drug used to treat Covid-19 coronavirus symptoms, purchased from a government dispensary, in Chennai (Photo: PTI)

The Indian government, on Wednesday, claimed it has ramped up the production of Remdesivir, an anti-viral drug prescribed for treating moderate-to-critical Covid patients, by 10 times. From 1 million vials

Also Read

Bharat Biotech's Covaxin effective against Covid-19 UK strain: ICMR

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

Covaxin's efficacy shows immense strength of Atmanirbhar Bharat: ICMR chief

From crunch time to a bigger bite, Apple's India biz makes a turnaround

How closing schools for another year may set India back a few years

Scientists agree Covid is airborne, want overhaul of ventilation systems

Should my child get coronavirus vaccine? 7 questions answered by an expert

Huge public-pvt effort needed to boost health if there's third Covid wave

'INNergise' to Mood Diet: Five-star hotels go all out to beat Covid blues

What is mucormycosis, the deadly fungal infection among Covid patients

First Published: May 19 2021 | 4:53 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to